Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03336216
Title A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

pancreatic adenocarcinoma

Therapies

Cabiralizumab + Gemcitabine + Nab-paclitaxel + Nivolumab

Cabiralizumab + Nivolumab

Fluorouracil + Irinotecan + Leucovorin

Gemcitabine + Nab-paclitaxel

Cabiralizumab + Fluorouracil + Irinotecan + Leucovorin + Nivolumab

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CAN

Facility Status City State Zip Country Details
Mayo Clinic - PPDS Phoenix Arizona 85054 United States Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
Ucla Medical Center Los Angeles California 90095 United States Details
University Of Colorado Aurora Colorado 80045 United States Details
Florida Cancer Specialists - South Fort Myers Florida 33901 United States Details
Florida Cancer Specialists - North Saint Petersburg Florida 33705 United States Details
Johns Hopkins University Baltimore Maryland 21287 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute. Boston Massachusetts 02114 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Laura & Isaac Perlmutter Cancer Ctr at NYU Langone New York New York 10016 United States Details
Memorial Sloan Kettering Nassau New York New York 10065 United States Details
University Of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
UPMC Pittsburgh Pennsylvania 15232 United States Details
Tennessee Oncology, PLLC - SCRI - PPDS Nashville Tennessee 37203 United States Details
Ut Southwestern Medical Center Dallas Texas 75235 United States Details
Md Anderson Houston Texas 77030 United States Details
University of Washington Seattle Washington 98109 United States Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Local Institution Kingston Ontario K7L 2V7 Canada Details
Local Institution Toronto Ontario M5G 2M9 Canada Details
Local Institution Herlev 2730 Denmark Details
Universitaetsklinik Heidelberg Heidelberg 69120 Germany Details
Universitatsmedizin Mannheim Mannheim 68167 Germany Details
Universitaetsklinikum Ulm Ulm 89081 Germany Details
Univ. Klinikum Wuerzburg Wuerzburg 97080 Germany Details
I.O.V. Istituto Oncologico Veneto Ircss Padova Padova Italy Details
Policlinico Gemelli Rome 00168 Italy Details
Local Institution Kashiwa-shi Chiba 2778577 Japan Details
Local Institution Chuo-ku Tokyo 1040045 Japan Details
Local Institution Seoul 03080 Korea, Republic of Details
Local Institution Seoul 06351 Korea, Republic of Details
H. Univ. Vall dHebron Barcelona 08035 Spain Details
Hospital Gral. Univ. Gregorio Maranon Madrid 28007 Spain Details
Hosp Univer 12 De Octubre Madrid 28041 Spain Details
Kantonsspital Graubuenden Chur 7000 Switzerland Details
Centre hospitalier universitaire Vaudois (CHUV) Lausanne 1011 Switzerland Details
Local Institution Taipei 10002 Taiwan Details
Local Institution Taipei 11217 Taiwan Details
Local Institution Glasgow G12 0YN United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field